BioCina and NovaCina Merger Bolsters Global CDMO Industry
13 Jan 2025 //
PR NEWSWIRE
Centivax Selects BioCina For cGMP Manufacturing Of Influenza Vaccine
10 Oct 2024 //
PRESS RELEASE
EnGeneIC Selects BioCina To Advance Ground-Breaking Cancer Treatment
24 Sep 2024 //
PRESS RELEASE
CDMO BioCina Partners with CelluTx
03 Jun 2024 //
PRESS RELEASE
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma
05 Mar 2024 //
PRESS RELEASE
BioCina and NovaCina Forge Strategic Alliance
27 Feb 2024 //
PR NEWSWIRE
BioCina Expands Partnership with GPN Vaccines
06 Nov 2023 //
PR NEWSWIRE
BioCina awarded Grants to develop enabling technologies for MFG of mRNA vaccines
26 Apr 2023 //
PR NEWSWIRE
Contract manufacturers BioCina and Genezen name new CEOs
16 Mar 2023 //
ENDPTS
BioCina Names Mark Womack CEO
14 Mar 2023 //
CONTRACT PHARMA